找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Personalized Pathway-Activated Systems Imaging in Oncology; Principal and Instru Tomio Inoue,David Yang,Gang Huang Book 2017 The Editor(s)

[復(fù)制鏈接]
查看: 14522|回復(fù): 35
樓主
發(fā)表于 2025-3-21 17:18:54 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology
副標(biāo)題Principal and Instru
編輯Tomio Inoue,David Yang,Gang Huang
視頻videohttp://file.papertrans.cn/745/744519/744519.mp4
概述Elucidates the benefits and pitfalls of current clinic FDG PET.Enriches understanding of moving radiopharmaceuticals from the workbench to the clinic.Provides translational research for clinical discu
圖書(shū)封面Titlebook: Personalized Pathway-Activated Systems Imaging in Oncology; Principal and Instru Tomio Inoue,David Yang,Gang Huang Book 2017 The Editor(s)
描述.This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications. We now are at the cutting edge of providing personalized treatment with increased use in oncology of these new radiopharmaceuticals. Trends in high-resolution instrumentation development, quality assurance systems and regulatory compliance for radiopharmaceuticals, clinical evaluation of radiopharmaceuticals, and benefits and pitfalls of the current clinical FDG PET are discussed..Radiopharmaceuticals are used for diagnosis of diseases of the central nervous and cardiovascular systems and for staging, restaging, and treatment planning for cancers. Nuclear biomarkers allow precise measurement of molecular pathways on a whole-body image upon administration of functional radiolabeled agents, and nuclear imaging agentshave potential use in patient selection, pharmacokinetic, dosage-finding, and proof-of-concept studies. Nuclear imaging agents and hybrid instrumentation also provide sensitive and specific answers for differential responsiveness in therapeutic outcome..This book serves as a reference for moving the discovery and development of radiopharma
出版日期Book 2017
關(guān)鍵詞Radiopharmaceutical; Theranostic; Personalized treatment; FDG PET; Nuclear biomarker; Nuclear imaging
版次1
doihttps://doi.org/10.1007/978-981-10-3349-0
isbn_softcover978-981-10-9850-5
isbn_ebook978-981-10-3349-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor
The information of publication is updating

書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology影響因子(影響力)




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology被引頻次




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology被引頻次學(xué)科排名




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology年度引用




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology年度引用學(xué)科排名




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology讀者反饋




書(shū)目名稱(chēng)Personalized Pathway-Activated Systems Imaging in Oncology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:55:11 | 只看該作者
第144519主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 03:03:02 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 07:26:49 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 10:16:29 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 14:22:53 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 18:13:28 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 21:58:29 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 05:24:42 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 06:13:55 | 只看該作者
10樓
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-29 05:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
牡丹江市| 内乡县| 濮阳市| 洪洞县| 华容县| 广安市| 永济市| 大宁县| 页游| 通州市| 彩票| 德惠市| 临漳县| 双桥区| 木兰县| 兰州市| 醴陵市| 姜堰市| 潮安县| 清流县| 北京市| 彰化市| 萨迦县| 磐安县| 合水县| 杭州市| 蛟河市| 清苑县| 历史| 温州市| 榆林市| 昔阳县| 通江县| 济南市| 巴中市| 内黄县| 全州县| 孟津县| 寿宁县| 苗栗县| 白水县|